Top compounds associated with response to MYBL2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	vincristine	CTRPv2	pan-cancer	AAC	0.079	0.01
mRNA	lenalidomide	GDSC1000	pan-cancer	AAC	0.093	0.02
mRNA	selumetinib:GDC-0941 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.091	0.02
mRNA	BRD-K19103580	CTRPv2	pan-cancer	AAC	0.097	0.02
mRNA	CCT018159	GDSC1000	pan-cancer	AAC	-0.088	0.02
mRNA	OSI-930	CTRPv2	pan-cancer	AAC	0.092	0.02
mRNA	KU-55933	CTRPv2	pan-cancer	AAC	0.092	0.02
mRNA	tanespimycin:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.082	0.02
mRNA	triazolothiadiazine	CTRPv2	pan-cancer	AAC	0.076	0.02
mRNA	KX2-391	CTRPv2	pan-cancer	AAC	0.08	0.02

Download CSV